These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7918160)

  • 1. Sensitive monitoring of polyclonal antilymphocyte agents in renal transplantation.
    Clark KR; Taylor RM; Forsythe JL
    Clin Transpl; 1993; ():267-74. PubMed ID: 7918160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose ATGAM treatment sufficiently reduces total T-cell counts and remains clinically effective in prophylactic and anti-rejection protocols.
    Ekberg H; Källén R; Schatz H; Persson NH
    Transplant Proc; 1995 Dec; 27(6):3430-1. PubMed ID: 8540035
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 4. Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
    Thomas F; Cunningham P; Thomas J; Gross U; Gaskins D; Sash C; Parker K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1874-8. PubMed ID: 3547892
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-day or ten-day ATG treatment for steroid-resistant rejection in kidney transplanted patients.
    Olausson M; Mjörnstedt L; Blohmé I
    Transplant Proc; 1995 Dec; 27(6):3434-5. PubMed ID: 8540037
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring antithymocyte globulin in renal transplantation.
    Clark K
    Ann R Coll Surg Engl; 1996 Nov; 78(6):536-40. PubMed ID: 8943640
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation.
    Buchler M; Thibault G; al Najjar A; Valentin JF; Guerraoui A; Nivet H; Bardos P; Lebranchu Y
    Transplant Proc; 1996 Oct; 28(5):2817-8. PubMed ID: 8908076
    [No Abstract]   [Full Text] [Related]  

  • 9. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
    Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
    Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro donor-specific hyporesponsiveness and T cell subsets in renal allograft recipients.
    Bas J; Mestre M; Griñó JM; Massip E; Castelao AM; Romeu A; González L; Valls A; Buendía E
    Allergol Immunopathol (Madr); 1993; 21(4):136-40. PubMed ID: 8237717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
    Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
    Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose versus low-dose steroid therapy in conjunction with rabbit anti-human lymphocyte serum: flow cytometric monitoring of lymphocyte parameters.
    Green WF; Niblack GD; Richie RE; Johnson HK; MacDonell RC; Tallent MB
    Transplant Proc; 1984 Dec; 16(6):1517-9. PubMed ID: 6390857
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of three immunosuppressive drug protocols on cadaver renal transplantation costs after 4 years of therapy.
    Canafax DM; Carleton BC; Matas AJ; Payne WD; Dunn DL; Sutherland DE; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1692-3. PubMed ID: 8442239
    [No Abstract]   [Full Text] [Related]  

  • 19. ATG in steroid-resistant acute rejection in living related kidney transplantation: long-term evaluation.
    Bakr MA; Foda MA; Sally S; Sobh MA; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3161-2. PubMed ID: 7998103
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
    Chen M; Wade J; Levy GA; Greig PD
    Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.